Blood lead levels (continuous)Blood lead level at end of duration Scale: 0–30 · children (aged 0–6 years)
2 findings from 1 review
Cognitive and neurobehavioural outcomes · children (aged 0–6 years)
2 findings from 1 review
Household dust: floor dust lead levels · children (aged 0–6 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) child vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events · children aged 5 years and under
1 finding from 1 review
Emotionalism (primary outcome) · emotionalism after stroke
It is very uncertain whether pharmaceutical interventions changes emotionalism (primary outcome) compared with placebo (very low certainty).
1 finding from 1 review
Emotionalism: mean scores at end of treatment ‐ Pathological Laughter and Crying Scale · emotionalism after stroke
1 finding from 1 review
Depression: Mean scores at end of treatment · emotionalism after stroke
1 finding from 1 review
Cognitive function · emotionalism after stroke
1 finding from 1 review
Activities of daily living · emotionalism after stroke
1 finding from 1 review
Adverse events: 1. death: at end of treatment · emotionalism after stroke
Pharmaceutical interventions showed no clear difference in adverse events: 1. death: at end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Activities of daily living · stroke survivors with hearing, smell, and taste perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life and participation ‐ mobility and navigation intervention for not Pusher Syndrome (Analysis 1.2) · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Psychological and mental health · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perception · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · stroke survivors with somatosensory perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · stroke survivors with tactile perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Extended activities of daily living · stroke survivors with tactile perception disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life and participation ‐ mobility and navigation (Analysis 3.1) · stroke survivors with tactile perception disorders
Rehabilitation interventions showed no clear difference in quality of life and participation ‐ mobility and navigation… compared with no treatment or control; GRADE not reported.
1 finding from 1 review